Citigroup Inc Surmodics Inc Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Surmodics Inc stock. As of the latest transaction made, Citigroup Inc holds 9,747 shares of SRDX stock, worth $285,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,747
Previous 10,928
10.81%
Holding current value
$285,392
Previous $432,000
31.25%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SRDX
# of Institutions
140Shares Held
12.1MCall Options Held
31.3KPut Options Held
17.9K-
Black Rock Inc. New York, NY1.17MShares$34.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY849KShares$24.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$23.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$23.1 Million1.99% of portfolio
-
Morgan Stanley New York, NY676KShares$19.8 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $410M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...